A 37-year-old woman with cerebral palsy and a rapid cycling bipolar affective disorder developed drowsiness and slurred speech when being treated with a combination of haloperidol and a low dose of carbamazepine. This effect occurred twice but did not appear when the patient was given carbamazepine alone at much higher doses. This suggests that some patients who appear intolerant of carbamazepine may still benefit from this drug if concomitant haloperidol therapy is ceased.
References
1.
BallengerJ. C.PostR. M. (1980), Carbamazepine in manic depressive illness: a new treatment, American Journal of Psychiatry137, 782–90
2.
BirkhimerL. J.CurtisJ. L.JannM. W. (1985), Use of carbamazepine in psychiatric disorders, Clinical Pharmacy4, 425–34
3.
ChaudryR. P.WatersB. G. H. (1983), Lithium and carbamazepine interaction: possible neurotoxicity, Journal of Clinical Psychiatry44, 31–2
4.
JannM. W.EreshefskyL.SakladS. R. (1985), Effects of carbamazepine on plasma haloperidol levels, Journal of Clinical Psychopharmacology5, 106–9
5.
KanterG. L.YerevanianB. I.CicconeR. (1984), Case report of a possible interaction between neuroleptics and carbamazepine, American Journal of Psychiatry141, 1101–2
6.
OkumaT. (1983), Therapeutic and prophylactic effects of carbamazepine in bipolar disorder, Psychiatric Clinics of North America6, 157–74
7.
ReynoldsE. H. (1975), Neurotoxicity of carbamazepine, inPennyJ. K.DalbyD. D. (eds), Advances in Neurology, Raven Press, New York, 343–53
8.
ShuklaS.GodwinC. D.LongL. E. B.MillerM. G. (1984), Lithium-carbamazepine neurotoxicity and risk factors, American Journal of Psychiatry141, 1604–6
9.
WraaeO. (1978), The pharmacokinetics of lithium in the brain, cerebrospinal fluid and serum of the rat, British Journal of Pharmacology64, 273–9
10.
YerevanianB. I.HodgemanC. H. (1985), A haloperidol carbamazepine interaction in a patient with rapid-cycling disorder (letter), American Journal of Psychiatry142, 785–6
